AstraZeneca Pharma India

AstraZeneca Pharma India (‘AstraZeneca’), a leading science-led biopharmaceutical company and Sun Pharmaceutical Industries,…

Durvalumab in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Durvalumab as adjuvant…

Durvalumab in combination with carboplatin and paclitaxel is now also indicated for first-line treatment of adults with primary…

This treatment can enhance hyperkalaemia management in adults, a condition characterised by elevated potassium levels that often…

Eculizumab is approved in India to manage two rare diseases- Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic…

Additional indications for treatment of HER2 low breast cancer and HER2 positive gastric / gastro-oesophageal cancer

This drug is used for the treatment of critical bleeding conditions associated with use of novel anticoagulants (Factor Xa…

The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted…

Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma…

Revenue from operations stood at Rs 175.40 crores for the quarter under consideration. It was Rs 193.57 crores for the same period…